Assistant/Associate Professor-Cancer Metabolism

Job ID
2024-16715
Campus
Bronx
Employee Classification
Faculty
Department
Molecular Pharmacology
Position Type
Regular Full-Time

POSITION RESPONSIBILITIES

The Department of Molecular Pharmacology at the Albert Einstein College of Medicine is seeking candidates for a tenure-track position in cancer metabolism. We are looking for creative early- and mid-career applicants with bold vision and demonstrated excellence in research at the interface of cancer biology, metabolism, immunometabolism, tumor microenvironment and tumor metastasis, who apply their expertise to important problems in basic and translational sciences

 

The new recruit will join the Dept. of Molecular Pharmacology and the Montefiore-Einstein Comprehensive Cancer Center. Einstein provides an outstanding and supportive research environment, with world class shared facilities and multiple NIH Centers (Cancer, Diabetes, Aging, AIDS, and Intellectual and Developmental Disabilities). Einstein is a part of the Montefiore Health Care System, which brings the advantages of close interactions with eminent clinicians as well as a demographically unique patient base. 

 

Please send a cover letter, curriculum vitae, concise (1-2 pages) summary of previous research contributions and a well-articulated research plan (2-3 pages).  (Please upload all documents when applying for the role, when prompted to submit Cover letter, CV and Other supporting documents).

 

The application deadline is Sept 1, 2024. 

QUALIFICATIONS

Interested candidates should have a Ph.D., M.D., or M.D./Ph.D. in Cell Biology, Cancer Biology, Biochemistry, Diabetes/Metabolism, Immunology, or related academic disciplines.

New faculty will move into newly renovated space, and start up packages are highly competitive.

We will consider applicants years of experience/accomplishments when deciding final salary.

Minimum Salary Range

USD $130,000.00/Yr.

Maximum Salary Range

USD $160,000.00/Yr.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed